Domenico (Dinko) Valerio

Vice-Chairman

  General Partner Aescap Venture Management BV
Dinko Valerio is a scientist and entrepreneur who founded and successfully built the biomedical company Crucell N.V., a NASDAQ- and Euronext listed company. He was CEO of Crucell N.V. until 2004. In 1999 he also founded Galapagos Genomics N.V. as a spinout from Crucell N.V. Galapagos Genomics N.V. went public on the Euronext stock market in 2005.
In 2005 Dinko co-founded Aescap Venture Management together with Michiel de Haan, the founder and previous Managing Partner of Atlas Venture. Aescap Venture Fund I manages € 103 million and is dedicated to investments in European Biomedical Companies.
Dinko Valerio holds a professorship in Gene Therapy at the Leiden University since 1992.
In 1985 Dinko was a ‘visiting scientific specialist’ at Genentech Inc., San Francisco, USA. He was a post-doctoral fellow at the Salk Institute, San Diego, USA from 1986 to 1987. He received his Master of Science degree in Biology from University of Amsterdam and completed his Ph.D. in Molecular Genetics with Honors at Leiden University in 1986.
He published over 100 articles in peer-reviewed Journals and is an inventor on 80 patents (issued from 11 patent-families).